Home»2017»1.14 Dechra Veterinary Products Enters Into an Exclusive North American Sales and Marketing Partnership with Kane Biotech for Patented Dental and Dermatology Technology

1.14 Dechra Veterinary Products Enters Into an Exclusive North American Sales and Marketing Partnership with Kane Biotech for Patented Dental and Dermatology Technology

0
Shares
Pinterest Google+

Company press release

Dechra Veterinary Products is pleased to announce a North American partnership with Kane Biotech, a Canadian based technology company engaged in the development of products that prevent and remove microbial biofilms. The initial joint project will be the development and launch of a premium line of veterinary exclusive oral health products designed to fight plaque and tartar utilizing Kane’s patented and patent-pending biofilm and mineral chelation technology.

“With periodontal disease being a leading contributor to health problems in pets, we are eager to expand our dental range with clinically-proven, innovative technology that is safe and efficacious. We are pleased to partner with Kane Biotech to further develop their technology in the veterinary market. Kane’s intellectual property has received positive feedback from many Key Opinion Leaders,” says Mike Eldred, President of Dechra North America.

Mark Ahrens-Townsend, CEO of Kane commented on the partnership with Dechra, “We are pleased to have partnered with Dechra, a leader in the veterinary dental and dermatology markets. In a controlled clinical study in sixty healthy dogs, the calculus score for the treated dogs was 25.4% lower than the control group. The study demonstrated our technology is effective in preventing dental calculus. We look forward to a long-term strategic partnership with Dechra.”

In addition to the dental applications, Dechra and Kane will further partner to develop new dermatological therapies employing this patented and patent-pending biofilm technology and dispersin-B, another patented molecule.

The Kane oral health product range is currently being sold under the brand StrixNB. Dechra expects to transition these dental products under a new Dechra tradename over the coming months and product will be available for veterinarians to purchase through select veterinary distributors shortly thereafter.

About Dechra
Dechra is an international specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. The majority of Dechra’s products are focused on key therapeutic categories where we have leading market positions, and many of our products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. For more information, please visit: www.dechra.com.

Previous post

1.13 Dechra Pharmaceuticals Says Half-Year 2017 Revenue Up at 172.6 Mln

Next post

1.15 DSM And Evonik Partner On Algae Additives

No Comment

Leave a reply

Your email address will not be published. Required fields are marked *

RETURN TO TABLE OF CONTENTS